Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > South America
Category: All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing
(93 reports matching your criteria)
< prev 1    3  4  
Peru Pharmaceuticals and Healthcare Report Q4 2015
8/26/2015 | published by: BMI Research
... incoming years. A rising burden of chronic conditions driving a growing medicine demand will keephealthcare spending on a positive trajectory in the country, assisted by Peru's positive economic outlook for2015. Headline Expenditure Projections Pharmaceuticals: PEN4.7bn ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q4 2015
8/12/2015 | published by: BMI Research
... and healthcare suppliers. Despite remaining concerns surrounding Colombia's counterfeitdrug market, the country's overwhelming demand for medical access will keep health and medicinespending on a positive trajectory over the long term. Headline Expenditure Projections Pharmaceuticals: COP8,643bn ...  |  read more...
USD 1,295
Argentina Pharmaceuticals and Healthcare Report Q4 2015
8/12/2015 | published by: BMI Research
... Moreover, a recent agreement aimed at improving access to high value medicines andtreatments for rare diseases will greatly improve the appeal of Mercosur countries, including Argentina, tomultinationals, posing upside risks to our forecasts. We also ...  |  read more...
USD 1,295
Insulin Market in Ecuador to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Ecuador. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Uruguay to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Uruguay. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Bolivia to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Bolivia. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Colombia to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Colombia. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Ecuador to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Ecuador. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Insulin Market in Argentina to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Argentina. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Argentina to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Argentina. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Insulin Market in Colombia to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Colombia. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Chile to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Chile. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Penicillin and Streptomycin Market in Peru to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in Peru. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report ...  |  read more...
USD 541
Insulin Market in Bolivia to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Bolivia. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
Insulin Market in Chile to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Chile. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
Insulin Market in Peru to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Peru. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
Insulin Market in Uruguay to 2019 - Market Size, Development, and Forecasts
8/3/2015 | published by: Global Research & Data Services Oy
... the actual market situation, and future outlook for insulin in Uruguay. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ...  |  read more...
USD 541
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
7/13/2015 | published by: GlobalData
... information on and analysis of the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the country‚Äôs healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare ...  |  read more...
USD 1,995
Chile Pharmaceuticals and Healthcare Report Q3 2015
7/8/2015 | published by: BMI Research
... the forecast period. In addition, the rising incidence of chronic, non-communicabledisease will coincide with a high reliance on imported pharmaceuticals to safeguard the value share ofpatented prescription treatments. However, a dependence on the export of ...  |  read more...
USD 1,295
Venezuela Pharmaceuticals and Healthcare Report Q3 2015
7/8/2015 | published by: BMI Research
... the country's worseningpolitical and economic landscapes, severe drug shortages, and severely limited affordability levels. For now,multinational pharmaceutical companies show no sign of retreat from the market, however, expectations forfurther deterioration of Venezuela's economy will likely ...  |  read more...
USD 1,295
Ecuador Pharmaceuticals and Healthcare Report Q3 2015
7/1/2015 | published by: BMI Research
... years. The country's fast growing healthcaremarket will also benefit investors, though limited medical access and drug shortages in Ecuador willremain barriers to the country's otherwise positive outlook. Headline Expenditure Projections Pharmaceuticals: USD1.5bn in 2014 to ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report Q3 2015
6/3/2015 | published by: BMI Research
... as the demandfor medical provision as well as access to necessary healthcare improves in the country. Limited drugapprovals and the Ministry of Health's implication within the Petrobras scandal will, however, continue togenerate risks within the ...  |  read more...
USD 1,295
Calming and Sleeping in Peru
5/12/2015 | published by: Euromonitor International
... without consulting a psychiatrist which is surrounded by myths about mental illness. Euromonitor International's Calming and Sleeping in Peru report offers a comprehensive guide to the size and shape of the market at a national ...  |  read more...
USD 990
Brazil Pharmaceuticals and Healthcare Report Q2 2015
4/1/2015 | published by: BMI Research
... America. However, low affordability and increasing generic drug competition willhamper opportunities for innovative drugmakers as the country continues to develop its economy. Headline Expenditure Projections Pharmaceuticals: BRL62.0bn (USD26.3bn) in 2014 to BRL65.3bn (USD25.6bn) in 2015; ...  |  read more...
USD 1,295
Latin American Contract Research Organization Market
3/10/2015 | published by: Frost & Sullivan
... 2016, behind the United States, China, and Japan. The main drivers for market growth are generic drugs manufactured by local pharmaceutical companies and biosimilars manufactured both by multinational and local pharmaceutical companies. In 2013, the ...  |  read more...
USD 6,000
< prev 1    3  4